Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors
Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
The goal of this exploratory study is to test whether [18F]3F-PHPG can be used reliably to
map the locations of tumors in patients with neuroendocrine tumors. If so, the results of
this study will be used to support further development of [18F]3F-PHPG as a clinical tool for
neuroendocrine tumor localization and staging.